The DOI matches its Crossref record; 466 of the 466 references it cites were found in a registry or an index.
Apoptosis and Necrosis in the Liver
Open accessAbstract
Because of its unique function and anatomical location, the liver is exposed to a multitude of toxins and xenobiotics, including medications and alcohol, as well as to infection by hepatotropic viruses, and therefore, is highly susceptible to tissue injury. Cell death in the liver occurs mainly by apoptosis or necrosis, with apoptosis also being the physiologic route to eliminate damaged or infected cells and to maintain tissue homeostasis. Liver cells, especially hepatocytes and cholangiocytes, are particularly susceptible to death receptor‐mediated apoptosis, given the ubiquitous expression of the death receptors in the organ. In a quite unique way, death receptor‐induced apoptosis in these cells is mediated by both mitochondrial and lysosomal permeabilization. Signaling between the endoplasmic reticulum and the mitochondria promotes hepatocyte apoptosis in response to excessive free fatty acid generation during the metabolic syndrome. These cell death pathways are partially regulated by microRNAs. Necrosis in the liver is generally associated with acute injury (i.e., ischemia/reperfusion injury) and has been long considered an unregulated process. Recently, a new form of “programmed” necrosis (named necroptosis) has been described: the role of necroptosis in the liver has yet to be explored. However, the minimal expression of a key player in this process in the liver suggests this form of cell death may be uncommon in liver diseases. Because apoptosis is a key feature of so many diseases of the liver, therapeutic modulation of liver cell death holds promise. An updated overview of these concepts is given in this article. © 2013 American Physiological Society.Compr Physiol 3:977‐1010, 2013.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–466 of 466
Bhathal, P. S., & Gall, J. A. M. (1985) · Liver International · doi:10.1111/j.1600-0676.1985.tb00254.x · Cited by 78
Oncosis represents the main type of cell death in mouse models of cholestasis
Fickert, P., Trauner, M. A., Fuchsbichler, A., Zollner, G., Wagner, M., Marschall, H., Zatloukal, K., & Denk, H. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.016 · Cited by 77
Nakamoto, Y., Kaneko, S., Fan, H. S., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020633 · Cited by 77
Role of IL-17A in Neutrophil Recruitment and Hepatic Injury after Warm Ischemia–Reperfusion Mice
Kono, H., Fujii, H., Ogiku, M., Hosomura, N., Amemiya, H., Tsuchiya, M., & Hara, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100490 · Cited by 77
Fiorucci, S., Cipriani, S., Mencarelli, A., Baldelli, F., Bifulco, G., & Zampella, A. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711796355258 · Cited by 76
Antitumor Immunity Produced by the Liver Kupffer Cells, NK Cells, NKT Cells, and CD8+CD122+T Cells
Seki, S., Nakashima, H., Nakashima, M., & Kinoshita, M. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/868345 · Cited by 75
Takikawa, Y., Miyoshi, H., Rust, C., Roberts, P. J., Siegel, R. M., Mandal, P. K., Millikan, R. E., & Gores, G. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24835 · Cited by 75
Self-citationBursch, W., D�sterberg, B., & Schulte‐Hermann, R. (1986) · Archives of Toxicology · doi:10.1007/bf00290542 · Cited by 75
Role of NF-κB on liver cold ischemia-reperfusion injury
Takahashi, Y., Ganster, R. W., Gambotto, A. A., Shao, L., Kaizu, T., Wu, T., Yagnik, G. P., Nakao, A., Tsoulfas, G., Ishikawa, T., et al. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00515.2001 · Cited by 75
Dong, Z., Patel, Y., Saikumar, P., Weinberg, J. M., & Venkatachalam, M. A. (1998) · PubMed · Cited by 74
Shimbo, K., Hsu, G. W., Nguyen, H. C. X., Mahrus, S., Trinidad, J. C., Burlingame, A. L., & Wells, J. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208616109 · Cited by 72
Mehal, W. Z., & Imaeda, A. B. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255352 · Cited by 71
The liver-specific microRNA miR-122: biology and therapeutic potential.
Filipowicz, W., & Grosshans, H. (2011) · Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques · doi:10.1007/978-3-7643-8989-5_11 · Cited by 70
Taniai, H., Hines, I. N., Bharwani, S., Maloney, R. E., Nimura, Y., Gao, B., Flores, S. C., McCord, J. M., Grisham, M. B., & Aw, T. Y. (2004) · Hepatology · doi:10.1002/hep.20217 · Cited by 70
Schuchmann, M., & Galle, P. R. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200107000-00005 · Cited by 68
Agarwal, R., Hennings, L. J., Rafferty, T. M., Letzig, L. G., McCullough, S. S., James, L. P., MacMillan-Crow, L. A., & Hinson, J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184192 · Cited by 67
Hand, N. J., Horner, A. M., Master, Z. R., Boateng, L. A., Guen, C. L. L., Uvaydova, M., & Friedman, J. R. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318244148b · Cited by 66
Fas-mediated cholangiopathy in the murine model of graft versus host disease
Ueno, Y., Ishii, M., Yahagi, K., Mano, Y., Kisara, N., Nakamura, N., Shimosegawa, T., Toyota, T., & Nagata, S. (2000) · Hepatology · doi:10.1053/he.2000.5764 · Cited by 65
Vallés, S. L., Blanco, A. M. A., Azorı́n, I., Guasch, R. M., Pascual, M., Gómez-Lechón, M. J., Renau‐Piqueras, J., & Guerri, C. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000099261.87880.21 · Cited by 64
A quantitative evaluation of apoptotic bodies in rat liver
Benedetti, A., Jézéquel, A. M., & Orlandi, F. (1988) · Liver International · doi:10.1111/j.1600-0676.1988.tb00987.x · Cited by 63
Bid Antisense Attenuates Bile Acid-Induced Apoptosis and Cholestatic Liver Injury
Higuchi, H., Miyoshi, H., Bronk, S. F., Zhang, H., Dean, N. S., & Gores, G. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29204-1 · Cited by 63
Self-citationClinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Festi, D., Montagnani, M., Azzaroli, F., Lodato, F., Mazzella, G., Roda, A., Biase, A. R. D., Roda, E., Simoni, P., & Colecchia, A. (2007) · Current Clinical Pharmacology · doi:10.2174/157488407780598171 · Cited by 62
Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes
Walter, D., Schmich, K., Vogel, S., Pick, R., Kaufmann, T., Sigloch, F. C., Haber, A., Neubert, K., McNelly, S., von Weizsäcker, F., et al. (2008) · Hepatology · doi:10.1002/hep.22541 · Cited by 61
Alisi, A. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.965 · Cited by 61
Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci
Pierce, R. H., Vail, M. E., Ralph, L., Campbell, J. S., & Fausto, N. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61101-7 · Cited by 60
Bak deficiency inhibits liver carcinogenesis: A causal link between apoptosis and carcinogenesis
Hikita, H., Kodama, T., Shimizu, S., Li, W., Shigekawa, M., Tanaka, S., Hosui, A., Miyagi, T., Tatsumi, T., Kanto, T., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.027 · Cited by 60
Death Receptor-Mediated Liver Injury
Akazawa, Y., & Gores, G. J. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-991510 · Cited by 58
Self-citationSuppression of Bcl-xL deamidation in human hepatocellular carcinomas.
Takehara, T., & Takahashi, H. (2003) · PubMed · Cited by 57
Werneburg, N. W., Bronk, S. F., Guicciardi, M. E., Thomas, L., Dikeakos, J. D., Thomas, G., & Gores, G. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.342238 · Cited by 57
Self-citationAlabraba, E., Lai, V., Boon, L., Wigmore, S. J., Adams, D., & Afford, S. C. (2007) · Hepatology · doi:10.1002/hep.22011 · Cited by 57
Currin, R. T., Caldwell-Kenkel, J. C., Lichtman, S. N., Bachmann, S., Takei, Y., Kawano, S., Thurman, R. G., & Lemasters, J. J. (1996) · Transplantation · doi:10.1097/00007890-199612150-00004 · Cited by 54
Hepatic mi R ‐29ab1 expression modulates chronic hepatic injury
Kogure, T., Costinean, S., Yan, I. K., Braconi, C., Croce, C. M., & Patel, T. C. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01578.x · Cited by 54
Antigen-presenting cells under the influence of alcohol
Lau, A. H., Szabó, G., & Thomson, A. W. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.09.005 · Cited by 54
Modulation of apoptosis as a target for liver disease
Eichhorst, S. T. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.83 · Cited by 54
Targeting IAP (Inhibitor of Apoptosis) Proteins for Therapeutic Intervention in Tumors
Vucic, D. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783769373 · Cited by 52
Altomare, E., Leo, M. A., & Lieber, C. S. (1984) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1984.tb05688.x · Cited by 51
Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00497.2006 · Cited by 50
Self-citationThe Immunophysiology of Biliary Epithelium
Fava, G., Glaser, S. S., Francis, H., & Alpini, G. D. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916318 · Cited by 49
Detection of soluble TRAIL in HBV infected patients and its clinical implications
Han, L. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i6.1077 · Cited by 48
Kaplowitz, N. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70094-5 · Cited by 47
Wong, L. T. L., Whitehouse, L. W., Solomonraj, G., & Paul, C. J. (1980) · Toxicology · doi:10.1016/0300-483x(80)90011-6 · Cited by 46
Guicciardi, M. E., Mott, J. L., Bronk, S. F., Kurita, S., Fingas, C. D., & Gores, G. J. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.10.005 · Cited by 46
Self-citationHoglen, N. C., Anselmo, D. M., Katori, M., Kaldas, M., Shen, X., Valentino, K. L., Lassman, C., Busuttil, R. W., Kupiec‐Weglinski, J. W., & Farmer, D. G. (2007) · Liver Transplantation · doi:10.1002/lt.21016 · Cited by 44
Differential modulation of cellular death and survival pathways by conjugated bile acids
Torchia, E. C., Stolz, A., & Agellon, L. B. (2001) · BMC Biochemistry · doi:10.1186/1471-2091-2-11 · Cited by 42
Chan, F. K.-M., & Baehrecke, E. H. (2012) · Cell · doi:10.1016/j.cell.2011.12.020 · Cited by 42
Schüngel, S., Buitrago‐Molina, L. E., Nalapareddy, P. D., Lebofsky, M., Manns, M. P., Jaeschke, H., Gross, A., & Vogel, A. (2009) · Hepatology · doi:10.1002/hep.23176 · Cited by 41
Characterization of the Caspase Inhibitor IDN-1965 in a Model of Apoptosis-Associated Liver Injury
Hoglen, N. C., Hirakawa, B. P., Fisher, C. D., Weeks, S., Srinivasan, A. N., Wong, A. M., Valentino, K. L., Tomaselli, K. J., Bai, X., Karanewsky, D. S., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29601-4 · Cited by 40
Jin, X., Chen, Y.-P., Kong, M., Zheng, L., Yang, Y., & Li, Y. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06864.x · Cited by 39
From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia
Walensky, L. D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.9339 · Cited by 38
Role of TRAIL and the pro-apoptotic Bcl-2 homolog Bim in acetaminophen-induced liver damage
Badmann, A., Keough, A., Kaufmann, T., Bouillet, P., Brunner, T. B., & Corazza, N. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.55 · Cited by 38
Giakoustidis, D. E., Iliadis, S., Tsantilas, D., Παπαγεωργίου, Γ., Kontos, N., Kostopoulou, E., Botsoglou, N. A., Gerasimidis, T., & Dimitriadou, A. (2003) · PubMed · Cited by 38
Apoptosis and hepatic allograft reperfusion injury
Kuo, P. C., Drachenberg, C., de la Torre, A., Bartlett, S. T., Lim, J. W., Plotkin, J. S., & Johnsona, L. B. (1998) · Clinical Transplantation · doi:10.1111/j.1399-0012.1998.tb01094.x · Cited by 37
BH3‐only protein bid participates in the Bcl‐2 network in healthy liver cells†
Hikita, H., Takehara, T., Kodama, T., Shimizu, S., Hosui, A., Miyagi, T., Tatsumi, T., Ishida, H., Ohkawa, K., Li, W., et al. (2009) · Hepatology · doi:10.1002/hep.23207 · Cited by 30
Dendritic cells in hepatitis C infection: can they (help) win the battle?
Dolganiuc, A., & Szabó, G. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0377-y · Cited by 30
Kurita, S., Mott, J. L., Cazanave, S. C., Fingas, C. D., Guicciardi, M. E., Bronk, S. F., Roberts, L. R., Fernández-Zapico, M. E., & Gores, G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018330 · Cited by 29
Self-citationc-FLIP Protects Mature T Lymphocytes from TCR-Mediated Killing
Zhang, N., Hopkins, K. C., & He, Y.-W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5368 · Cited by 29
Mitchell, C., Mahrouf‐Yorgov, M., Mayeuf-Louchart, A., Robin, M., Mansouri, A., Fromenty, B., & Gilgenkrantz, H. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.163 · Cited by 28
Modulation of Inflammasome Activity for the Treatment of Auto-inflammatory Disorders
Naik, E., & Dixit, V. M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9383-8 · Cited by 28
Gregory, C. D. (2009) · Nature · doi:10.1038/461181a · Cited by 28
Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancer
Weng, S., Yang, C.-Y., Li, C.-C., Sun, T.-P., Tung, S., Yen, J. J.-Y., Tsai, T., Chen, C., Chen, S. H., Hsiao, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.035 · Cited by 27
Caspase Inhibitors for the Treatment of Hepatitis C
Masuoka, H. C., Guicciardi, M. E., & Gores, G. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.05.010 · Cited by 26
Self-citationNalapareddy, P. D., Schüngel, S., Hong, J., Manns, M. P., Jaeschke, H., & Vogel, A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090304 · Cited by 26
An apoptosis biomarker goes to the HCV clinic†
Feldstein, A. E., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20479 · Cited by 21
Self-citationDeveloping strategies for liver fibrosis treatment
Murphy, F. R., Arthur, M. J. P., & Iredale, J. P. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.11.1575 · Cited by 20
Overexpression of Mcl-1 Attenuates Liver Injury and Fibrosis in the Bile Duct–Ligated Mouse
Kahraman, A., Mott, J. L., Bronk, S. F., Werneburg, N. W., Barreyro, F. J., Guicciardi, M. E., Akazawa, Y., Braley, K. E., Craig, R. W., & Gores, G. J. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0583-5 · Cited by 18
Self-citationInfluence of Kupffer cells on the early phase of liver reperfusion
Caban, A., Oczkowicz, G., Abdel-Samad, O., & Cierpka, L. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(01)02891-3 · Cited by 15
Cited by
Apoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582
Barreyro, F. J., Holod, S., Finocchietto, P. V., Camino, A. M., Aquino, J. B., Avagnina, A., Carreras, M. C., Poderoso, J. J., & Gores, G. J. (2015) · Liver International · doi:10.1111/liv.12570 · Cited by 294
Self-citationAcute liver failure: mechanisms of immune-mediated liver injury
Wu, Z., Han, M., Chen, T., Yan, W., & Ning, Q. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02262.x · Cited by 274
Hepatic microcirculation and mechanisms of portal hypertension
Gracia-Sancho, J., Marrone, G., & Fernández-Iglesias, A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0097-3 · Cited by 274
Naseem, S., Hussain, T., & Manzoor, S. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.01.002 · Cited by 72
Metadata
- Authors
- Guicciardi, M. E., Malhi, H., Mott, J. L., & Gores, G. J.
- Venue
- Comprehensive Physiology
- Publisher
- Wiley
- Published
- 2013-04
- Volume
- 3
- Issue
- 2
- Pages
- 977-1010
- ISSN
- 2040-4603 (ISSN-L)
- OpenAlex
- W1559041257
- Cited by
- 353
- References
- 466
- Type
- other
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.